Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est

Last updated: April 27, 2020
Sponsor: Centre Hospitalier Intercommunal Robert Ballanger
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Corona Virus

Coronavirus

Treatment

N/A

Clinical Study ID

NCT04366206
GHTRB-2020-01
  • All Genders

Study Summary

Healthcare centers treated several hundreds of patients with Covid-19 and prospectively gathered information in electronic format between March, 2020 to April, 2020. In the course of Covid-19 treatment, physicians employed several drugs, including hydroxychloroquine, azithromycin, lopinavir/ritonavir, tocilizumab, baricitinib, sarilumab, corticosteroids and systematic antibiotics (list is not exhaustive).

This cohort study aims to assess factors associated with clinical outcomes in patients hospitalized for Covid-19, by analyzing associations between treatments and outcomes.

All data are collected in electronical records during routine practice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • hospitalized for Covid-19

  • severe pneumonia defined as pulse O2 < 96% despite > 6L/min

Exclusion

Exclusion Criteria:

  • lack of consent

  • palliative care patients

  • patients in ICU

  • patients transferred from ICU

Study Design

Total Participants: 143
Study Start date:
March 14, 2020
Estimated Completion Date:
July 31, 2020

Study Description

Healthcare centers treated several hundreds of patients with Covid-19 and prospectively gathered information in electronic format between March, 2020 to April, 2020. In the course of Covid-19 treatment, physicians employed several drugs, including hydroxychloroquine, azithromycin, lopinavir/ritonavir, tocilizumab, baricitinib, sarilumab, corticosteroids and systematic antibiotics (list is not exhaustive).

This cohort study aims to assess factors associated with clinical outcomes in patients hospitalized for Covid-19.

Risk factors which will be studied include: baseline characteristics such as medical history and drugs with corresponding administration protocols.

Main outcomes include all-cause mortality, need for mechanical ventilation, for ICU transfer and all relevant biological syndromes.

All data are collected in electronical records during routine practice and additional data may be collected retrospectively.

Connect with a study center

  • Centre Hospitalier Intercommunal Robert Ballanger

    Aulnay-sous-Bois, 93600
    France

    Active - Recruiting

  • Groupe Hospitalier Pitie Salpetriere

    Paris, 75013
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.